After Musashi knockdown, multiple additional CSC characteristics were downregulated in breast cancer, including the AKT/PI3K pathway, CD133, pERK, tumor spheroid formation, CD44, and HES2 [30, 57, 59]. The gene discussed is PROM1; the disease is breast carcinoma.